Skip to main content
Clinical Trials/NCT04015856
NCT04015856CompletedNot Applicable

Impact Evaluation of the Tipping Point Project in Nepal: An Intervention to Prevent Early Child Marriage

Emory University2 sites in 1 country2,828 target enrollmentStarted: May 2, 2019Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
2,828
Locations
2
Primary Endpoint
Change in proportion of never married adolescents

Study Overview

Brief Summary

This project evaluates an intervention designed to prevent early child marriage in Nepal. The intervention consists of community dialogues, activist trainings, and community organized activities aimed at transforming social norms around gender. There will be three groups within the study: one exposed to the full program, one exposed to a lighter version of the program, and one that has not been exposed to the program. The impact evaluation will consist of qualitative and quantitative methods that compare these three groups.

Detailed Description

Each year, child marriage, before age 18 years, affects more than 10 million girls globally. The practice is associated with adverse maternal and child health outcomes and diminished long-term economic empowerment. About half of all child marriages occur in South Asia. A recent study in four high prevalence South Asian countries showed declines in girl-child marriage from 1991-1994 to 2005-2007, however, these declines were concentrated in the youngest ages. Namely, significant relative reductions occurred in the marriage of girls before age 14 years in all countries, however, little or no change was seen in the marriage of 16- to 17-year-old girls for any country except Bangladesh, where the prevalence of such marriages increased.

Tipping Point (TP) is an innovative program developed by Cooperative for Assistance and Relief Everywhere, Inc. (CARE) to change community social norms and build capacity among adolescent girls to become agents of change in their communities, with the ultimate goal of reducing the risk of child marriage.

The quantitative evaluation of the TP package will involve a three arm Cluster Randomized Controlled Trial (CRCT), where the arms are as follows:

  • Arm 1: Full TP intervention including emphasized social norms change
  • Arm 2: Light TP intervention without emphasized social norms change
  • Arm 3: Pure control

The overall evaluation in Nepal will start with the baseline study, followed by eighteen months of interventions. After the intervention phase, there will be a one year 'freeze' period, when no interventions will take place. After that one year, the end-line evaluation study will be conducted in Nepal to assess the impact of the packages.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
12 Years to 16 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Change in proportion of never married adolescents

Time Frame: Baseline, Month 30

The proportion of never-married adolescents (aged under 20) in each study arm will be examined.

Change in proportion of married adolescents

Time Frame: Baseline, Month 30

The proportion of married adolescents (aged under 20) in each study arm will be examined.

Secondary Outcomes

  • Change in attitudes on ASRHR among community adults(Baseline, Month 30)
  • Change in decision making(Baseline, Month 30)
  • Change in movement building among adolescent girls(Baseline, Month 30)
  • Change in social norms(Baseline, Month 30)
  • Change in Adolescent Sexual and Reproductive Health and Rights (ASRHR)(Baseline, Month 30)
  • Change in gender attitudes among community adults(Baseline, Month 30)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kathryn Yount

Professor

Emory University

Study Sites (2)

Loading locations...

Similar Trials

Preventing Early Child Marriage in Nepal | Clinical Trial